Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging
Creator
Xu, Feng
Zhang, Zhen
Shi, Chao
Li, Zhou
Sun, Wen
Du, Jianjun
Fan, Jiangli
Li, Haidong
Long, Saran
Ma, He
Peng, Xiaojun
Shao, Kun
Wang, Jingyun
Yao, Qichao
Zhou, Xiao
Source
Elsevier; Medline; PMC
abstract
Abstract Photodynamic therapy has been developed as a prospective cancer treatment in recent years. Nevertheless, conventional photosensitizers suffer from lacking recognition and specificity to tumors, which causing severe side effects to normal tissues, while the enzyme-activated photosensitizers are capable of solving these conundrums due to high selectivity towards tumors. APN (Aminopeptidase N, APN/CD13), a tumor marker, has become a crucial targeting substance owing to its highly expressed on the cell membrane surface in various tumors, which has become a key point in the research of anti-tumor drug and fluorescence probe. Based on it, herein an APN-activated near-infrared (NIR) photosensitizer (APN-CyI) for tumor imaging and photodynamic therapy has been firstly developed and successfully applied in vitro and in vivo. Studies showed that APN-CyI could be activated by APN in tumor cells, hydrolyzed to fluorescent CyI-OH, which specifically located in mitochondria in cancer cells and exhibited a high singlet oxygen yield under NIR irradiation, and efficiently induced cancer cell apoptosis. Dramatically, the in vivo assays on Balb/c mice showed that APN-CyI could achieve NIR fluorescence imaging (λem = 717 nm) for endogenous APN in tumors and possessed an efficient tumor suppression effect under NIR irradiation.
has issue date
2020-05-03
(
xsd:dateTime
)
bibo:doi
10.1016/j.biomaterials.2020.120089
bibo:pmid
32447103
has license
els-covid
sha1sum (hex)
9d7ebfb48928ae82891a82ccc60ddb90b85b4bb9
schema:url
https://doi.org/10.1016/j.biomaterials.2020.120089
resource representing a document's title
An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging
has PubMed Central identifier
PMC7196320
has PubMed identifier
32447103
schema:publication
Biomaterials
resource representing a document's body
covid:9d7ebfb48928ae82891a82ccc60ddb90b85b4bb9#body_text
is
schema:about
of
named entity 'severe'
named entity 'tissues'
named entity 'mitochondria'
named entity 'apoptosis'
named entity 'cancer'
named entity 'LACKING'
named entity 'SIDE EFFECTS'
named entity 'PROSPECTIVE'
named entity 'CYI'
named entity 'MEMBRANE SURFACE'
named entity 'CAUSING'
named entity 'singlet oxygen'
named entity 'cancer'
named entity 'substance'
named entity 'tumors'
named entity 'tumor marker'
named entity 'imaging'
named entity 'point'
named entity 'hydrolyzed'
named entity 'APN'
named entity 'author'
named entity 'photosensitizers'
named entity 'singlet oxygen'
named entity 'tumors'
named entity 'near-infrared'
named entity 'fluorescence imaging'
named entity 'enzyme'
named entity 'fluorescence'
named entity 'irradiation'
named entity 'tumor marker'
named entity 'Aminopeptidase'
named entity 'photosensitizer'
named entity 'NIR'
named entity 'tumors'
named entity 'photodynamic therapy'
named entity 'NMR spectra'
named entity 'DMEM'
named entity 'column chromatography'
named entity 'cancer therapeutics'
named entity 'hydrolyzed'
named entity 'solvent'
named entity 'metastasis'
named entity 'photodynamic therapy'
named entity 'SPF'
named entity 'Charge Transfer'
named entity 'objective lens'
named entity 'Balb/c'
named entity 'Calcein'
named entity 'microplate reader'
named entity 'photosensitizer'
named entity 'GGT'
named entity 'fluorophore'
named entity 'EPR'
named entity 'silica gel'
named entity '4T1'
named entity 'fluorescence'
named entity 'singlet oxygen'
named entity '2-hydroxy-4-methoxybenzaldehyde'
named entity 'Mass spectra'
named entity 'NaCl'
named entity 'biochemical'
named entity 'N-acetyl-L-cysteine'
named entity 'indole'
named entity 'reactive oxygen species'
named entity 'DMSO'
named entity 'photodynamic therapy'
named entity 'solvent'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 9
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software